A 25-Year Single Institution Experience With Surgery for Primary Mediastinal Nonseminomatous Germ Cell Tumors

Annals of Thoracic Surgery

Volumn 85, Issue 2, 2008, Pages 371-378

  Kesler, Kenneth A ^a   Rieger, Karen M ^a   Hammoud, Zane T ^a   Kruter, Laura E ^a   Perkins, Susan M ^a   Turrentine, Mark W ^a   Schneider, Bryan P ^a   Einhorn, Lawrence H ^a   Brown, John W ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; METASTASIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIMARY MEDIASTINAL NONSEMINOMATOUS GERM CELL TUMOR; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK ASSESSMENT; SCHOOL CHILD; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIANA; MALE; MEDIASTINAL NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THORACOTOMY; TREATMENT OUTCOME;

EID: 38349180500     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.09.020     Document Type: Article

References (20)

1. Einhorn L.H., and Donohue J.P. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87 (1977) 293-298
2. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15 (1997) 594-603
3. Bokemeyer C., Nichols C., Droz J., et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J Clin Oncol 20 (2002) 1864-1873
4. Kesler K.A., Rieger K.M., Ganjoo K.N., et al. Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery. J Thorac Cardiovasc Surg 118 (1999) 692-700
5. Vuky J., Bains M., Bacik J., et al. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum. J Clin Oncol 19 (2001) 682-688
6. Motzer R.J., Nichols C.J., Margolin K.A., et al. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 25 (2007) 247-256
7. Hinton S., Catalano P.J., Einhorn L.H., et al. Cisplatin, etoposide and bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial. Cancer 97 (2003) 1869-1875
8. Schneider B., Kesler K., Brooks J., Yiannoutsos C., and Einhorn L.H. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer. J Clin Oncol 2 (2004) 1195-1200
9. Kesler KA. Germ cell tumors of the mediastinum. In: Pearson FG et al (eds). Thoracic Surgery, 3rd Chapter 132. - In Press.
10. Wright C., and Kesler K.A. Surgical techniques and outcomes for primary mediastinal nonseminomatous germ cell tumors. Chest Surg Clin N Am 12 (2002) 707-715
11. Goss P., Schwertfeger L., Blackstein M., et al. Extragonadal germ cell tumors: a 14-year Toronto experience. Cancer 73 (1994) 1971-1979
12. Hidalgo M., Paz-Ares L., Rivera F., et al. Mediastinal nonseminomatous germ cell tumors treated with cisplatin-based combination chemotherapy. Ann Oncol 8 (1997) 555-559
13. Fizazi K., Culine S., Droz J., et al. Primary mediastinal nonseminomatous germ cell tumors: Results of modern therapy including cicplatin-based chemotherapy. J Clin Oncol 16 (1998) 725-732
14. Hartmann J.T., Nichols C.R., Droz J.P., et al. Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Nat Ca Institute 92 (2000) 54-61
15. Walsh G.L., Taylor G.D., Nesbitt J.C., and Amato R.J. Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors. Ann Thorac Surg 69 (2000) 337-343
16. Bokemeyer C., Schleucher N., Metzner B., et al. First-line sequential high-dose VIP chemotherapy with autologous transplant for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial. Br J Cancer 89 (2003) 29-35
17. Andrade R., Kesler K.A., Wilson J.L., et al. Short and long-term outcomes after large pulmonary resection for germ cell tumors following bleomycin-combination chemotherapy. Ann Thorac Surg 78 (2004) 1224-1229
18. Hartmann J.T., Nichols C.R., Droz J., et al. Prognostic variables for response and outcome in patients with extragondal germ-cell tumors. Ann Oncol 13 (2002) 1017-1028
19. Loehrer P.J., Gonin R., Nichols C.R., Weathers T., and Einhorn L.H. Vinblastine plus ifosfamide plus cisplatin an initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16 (1998) 2500-2504
20. Hartmann J., Einhorn L., Nichols C., et al. Second-line chemotherapy in patients with relapsed extragonadal non-seminomatous germ cell tumors: Results of an international multicenter analysis. J Clin Oncol 19 (2001) 1641-1648